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Oligonucleotide Therapeutics
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a 6-to-12-month duration of effect, oligonucleotide therapeutics
might become competitive not
only with biologics, but also with
orally administered drugs, an outcome that was unforeseeable only
a short while ago. Of course, the
future of inclisiran and oligonucleotide therapeutics is completely dependent on the demonstration of their safety.
Conjugated oligonucleotides are
chemically defined “large small
molecules” that can be synthesized in an advanced oligonucleotide lab within a day. They are
assembled from standard building blocks, phosphoramidites, in
an automatic fashion using solidphase chemistry. The cost of oligonucleotides is driven mainly by

the cost of its precursors and is
expected to be in the low hundreds of dollars per gram on a
commercial scale. With a yearly
dose of 300 to 500 mg, the manufacturing cost for this class of
drugs is on par with that of smallmolecule drugs and is probably
much lower than that of monoclonal antibodies. Although the
manufacturing cost accounts for
only a minority of the initial
market price of the drug, the
relative simplicity of the manufacturing process and the roomtemperature stability of the dried
oligonucleotides, which can be
brought to solution at the point
of care, might eventually make
this class of therapeutics widely
available for a broad population.

Disclosure forms provided by the author
are available at NEJM.org.
From RNA Therapeutics Institute, Program
in Molecular Medicine, University of Massachusetts Medical School, Worcester.
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A View from the Edge — Creating a Culture of Caring
Rana L.A. Awdish, M.D.

I

n 2008, an occult adenoma in
my liver ruptured, and I effectively bled to death in my own
hospital. I lost my entire blood
volume into my abdomen, triggering what’s known in trauma as
the Triad of Death — a kind of
suicidal spiral of the blood in
which it becomes too acidic and
too cold to clot. I would receive
more than 26 units of blood
products that night — packed
red cells, platelets, cryoprecipitate,
fresh frozen plasma. I would go
into multisystem organ failure,
my liver and kidneys would shut
down, I would be put on a ventilator, have a stroke and a complete hemodynamic collapse. The
baby I was 7 months pregnant
with would not survive, but I

would — thanks to the incredible skill and grace of the teams of
professionals who cared for me.
My recovery involved five major
operations including a right hepatectomy. I had to relearn to walk,
speak, and do many other things
I had taken for granted. But in the
process, as a patient, I learned
things about us — physicians
and other medical professionals
— that I might not have wanted
to know. I learned that though
we do so many difficult, technical
things so perfectly right, we fail
our patients in many ways.
As a patient, I was privy to
failures that I’d been blind to as a
clinician. There were disturbing
deficits in communication, uncoordinated care, and occasionally
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an apparently complete absence of
empathy. I recognized myself in
every failure.
When I overheard a physician
describe me as “trying to die on
us,” I was horrified. I was not trying to die on anyone. The description angered me. Then I cringed.
I had said the same thing, often
and thoughtlessly, in my training.
“He was trying to die on me.” As
critical care fellows, we had all
said it. Inherent in that accusation was our common attribution
of intention to patients: we subconsciously constructed a narrative in which the doctor–patient
relationship was antagonistic. It
was one of many revelatory moments for me.
I heard my colleagues say
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things to me in ways that inflicted more suffering, even when
they believed they were helping.
“We’re going to have to find
you a new liver, unless you want
to live here forever.”
“Are you sure your pain is an
eight? I just gave you morphine
an hour ago.”
“You should hold the baby,”
someone said. “I don’t want to
be graphic, but after a few days
in the morgue, their skin starts to

My experience changed me. It
changed my vision of what I wanted our organization to be, to embody. I wanted the value of empathetic, coordinated care to spread
through our system. I shared my
story openly. I wanted the system
leaders and every employee to
know that everything matters,
always. Every person, every time.
How do you build and maintain a culture of shared purpose
in the infinitely complex arena of

As a patient, I was privy to failures
that I’d been blind to as a clinician.
There were disturbing deficits in
communication, uncoordinated care,
and occasionally an apparently complete
absence of empathy. I recognized
myself in every failure.
break down and you won’t be able
to anymore, even if you change
your mind.”
Small things would gut me.
Receiving a bill for the attempted
resuscitation of the baby, for example. My husband took on the
task of reconciling the bill with
the lack of a baby. The billing department explained that the bill
was generated when we had
failed to enroll her in our insurance plan. No one could explain,
of course, at what exact juncture
we should have called our insurance company, seeing as how
she’d never technically been alive.
It took four phone calls to settle
the charges. A trivial oversight,
by a department ostensibly not
involved in patient care, had the
potential to bring me to my knees.

8

health care? How do you ensure
that you engender in employees a
dedication and commitment to
doing what’s right? Identifying
the gaps between the stated mission and values of an institution
and its actual delivery of care is
critical. As systems, we have to
recognize and acknowledge our
mistakes, our shortcomings, just
as individual physicians do. We
need to reflect on times when
our care has deviated from what
we intended — when we haven’t
been who we hoped to be. We
have to be transparent and allow
the failure to reshape us, to help
us reset our intention and mold
our future selves.
Bravely, my institution responded to my experience by radically
revising the way in which we in-
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troduce every new employee to our
organizational culture — colloquially referred to as “onboarding.” Our institutional leaders had
already launched a “Culture of
Caring” curriculum for nursing.
But they understood that to truly
change the culture, all new employees, including physicians,
needed to internalize our institution’s values. So they expanded
their efforts, incorporating the
failures and successes of my patient story to illuminate our
shared purpose and build an engaged culture.
Through the training that was
developed, participants learn to
articulate their purpose as distinct from their job. Transporters
hear how meaningful it was to
me when one of their own —
having seen me break down when
questioned by someone in radiology — took it upon himself to
warn the technicians performing
various tests not to ask about the
baby whose small pink wristband
was still in my chart. He asked
his colleagues to do the same. In
an 800-bed hospital, the transporters had united to form a protective enclosure around one patient.
Similarly, radiology technicians
learn what a kindness it was that
they stopped trying to awaken my
exhausted husband to move him
from my bedside for my portable
x-ray, instead throwing a lead
cover over him and letting him
sleep. The power of these stories
shows new employees that they
have a purpose and that they are
valued.
In addition, new employees
are taught to recognize different
forms of suffering: avoidable and
unavoidable. Our goal is to find
ways to mitigate suffering by re-
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sponding to the unavoidable kind
with empathy and by improving
our processes and procedures to
avoid inflicting the avoidable kind
whenever possible.
Our failures are analyzed, and
our successes shared. Consider the
power of that choice. Early on,
all new employees hear about how
we recognize and admit to our
failures. How we partner to ensure that transparency keeps us
from repeating our errors. How
we hold each other accountable.

By illuminating our failures, we
can begin an authentic conversation about shared purpose, resilience, and building an engaged
culture.
We believe that by focusing on
our missteps, we can ensure that
the path ahead is one of compassionate, coordinated care. When
we are ashamed, we can’t tell our
stories. They become inaccessible
to us. In the wake of painful experience, we all seek meaning. It
is the human thing to do, but
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it is also the job of great organizations. The stories we tell do
more than restore our faith in
ourselves. They have the power
to transform.
Disclosure forms provided by the author
are available at NEJM.org.
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